Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 13, 2022
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
Duffy Fischer Initiated (CC) at Hold and Held Target at $30 on, Oct 13th, 2022
Duffy Fischer of Goldman Sachs, Initiated "The Chemours Company" (CC) at Hold and Held Target at $30 on, Oct 13th, 2022.
Duffy has made no other calls on CC in the last 4 months.
There are 6 other peers that have a rating on CC. Out of the 6 peers that are also analyzing CC, 4 agree with Duffy's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Coleman of "Argus Research" Downgraded from Strong Buy to Hold on, Wednesday, October 5th, 2022
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $30 on, Tuesday, September 27th, 2022
- Joshua Spector of "UBS" Maintained at Hold with Increased Target to $37 on, Friday, July 29th, 2022
- Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $44 on, Tuesday, June 14th, 2022
These are the ratings of the 2 analyists that currently disagree with Duffy
- John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $46 on, Friday, September 23rd, 2022
- Arun Viswanathan of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Thursday, September 22nd, 2022
